112 related articles for article (PubMed ID: 9771693)
1. Why commonplace encounters turn to fatal attraction.
Sadelain M; Kieff E
Nat Genet; 1998 Oct; 20(2):103-4. PubMed ID: 9771693
[No Abstract] [Full Text] [Related]
2. Immunology. Sinking surveillance's flagship.
Klein G; Klein E
Nature; 1998 Oct; 395(6701):441, 443-4. PubMed ID: 9774094
[No Abstract] [Full Text] [Related]
3. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene.
Coffey AJ; Brooksbank RA; Brandau O; Oohashi T; Howell GR; Bye JM; Cahn AP; Durham J; Heath P; Wray P; Pavitt R; Wilkinson J; Leversha M; Huckle E; Shaw-Smith CJ; Dunham A; Rhodes S; Schuster V; Porta G; Yin L; Serafini P; Sylla B; Zollo M; Franco B; Bolino A; Seri M; Lanyi A; Davis JR; Webster D; Harris A; Lenoir G; de St Basile G; Jones A; Behloradsky BH; Achatz H; Murken J; Fassler R; Sumegi J; Romeo G; Vaudin M; Ross MT; Meindl A; Bentley DR
Nat Genet; 1998 Oct; 20(2):129-35. PubMed ID: 9771704
[TBL] [Abstract][Full Text] [Related]
4. X-linked lymphoproliferative syndrome.
Nelson DL; Terhorst C
Clin Exp Immunol; 2000 Dec; 122(3):291-5. PubMed ID: 11122230
[No Abstract] [Full Text] [Related]
5. XLP: one gene, many players.
Czar MJ; Schwartzberg PL
Clin Immunol; 2001 Jul; 100(1):2-3. PubMed ID: 11414739
[No Abstract] [Full Text] [Related]
6. The gene defective in X-linked lymphoproliferative disease controls T cell dependent immune surveillance against Epstein-Barr virus.
Howie D; Sayos J; Terhorst C; Morra M
Curr Opin Immunol; 2000 Aug; 12(4):474-8. PubMed ID: 10899030
[TBL] [Abstract][Full Text] [Related]
7. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM.
Sayos J; Wu C; Morra M; Wang N; Zhang X; Allen D; van Schaik S; Notarangelo L; Geha R; Roncarolo MG; Oettgen H; De Vries JE; Aversa G; Terhorst C
Nature; 1998 Oct; 395(6701):462-9. PubMed ID: 9774102
[TBL] [Abstract][Full Text] [Related]
8. X-linked lymphoproliferative disease: clinical, diagnostic and molecular perspective.
Gaspar HB; Sharifi R; Gilmour KC; Thrasher AJ
Br J Haematol; 2002 Dec; 119(3):585-95. PubMed ID: 12437631
[No Abstract] [Full Text] [Related]
9. SAP: natural inhibitor or grand SLAM of T cell activation?
Nichols KE; Koretzky GA; June CH
Nat Immunol; 2001 Aug; 2(8):665-6. PubMed ID: 11477397
[No Abstract] [Full Text] [Related]
10. Pathogenesis and diagnosis of X-linked lymphoproliferative disease.
Gilmour KC; Gaspar HB
Expert Rev Mol Diagn; 2003 Sep; 3(5):549-61. PubMed ID: 14510176
[TBL] [Abstract][Full Text] [Related]
11. [X-linked lymphoproliferative syndrome, EBV virus infection and defects in cytotoxicity lymphocyte regulation].
Malbrán A; Belmonte L; Ruibal-Ares B; Baré P; Bracco MM
Medicina (B Aires); 2003; 63(1):70-6. PubMed ID: 12673966
[TBL] [Abstract][Full Text] [Related]
12. The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease.
Engel P; Eck MJ; Terhorst C
Nat Rev Immunol; 2003 Oct; 3(10):813-21. PubMed ID: 14523387
[TBL] [Abstract][Full Text] [Related]
13. The X-linked lymphoproliferative disease gene product SAP is expressed in activated T and NK cells.
Nagy N; Mattsson K; Maeda A; Liu A; Székely L; Klein E
Immunol Lett; 2002 Jun; 82(1-2):141-7. PubMed ID: 12008045
[TBL] [Abstract][Full Text] [Related]
14. A spectrum of mutations in SH2D1A that causes X-linked lymphoproliferative disease and other Epstein-Barr virus-associated illnesses.
Sumegi J; Seemayer TA; Huang D; Davis JR; Morra M; Gross TG; Yin L; Romco G; Klein E; Terhorst C; Lanyi A
Leuk Lymphoma; 2002 Jun; 43(6):1189-201. PubMed ID: 12152986
[TBL] [Abstract][Full Text] [Related]
15. Disease-causing SAP mutants are defective in ligand binding and protein folding.
Li C; Iosef C; Jia CY; Gkourasas T; Han VK; Shun-Cheng Li S
Biochemistry; 2003 Dec; 42(50):14885-92. PubMed ID: 14674764
[TBL] [Abstract][Full Text] [Related]
16. The need for natural killer T cells.
MacDonald HR; Schümann J
Nat Med; 2005 Mar; 11(3):256-7. PubMed ID: 15746936
[No Abstract] [Full Text] [Related]
17. CDw150 associates with src-homology 2-containing inositol phosphatase and modulates CD95-mediated apoptosis.
Mikhalap SV; Shlapatska LM; Berdova AG; Law CL; Clark EA; Sidorenko SP
J Immunol; 1999 May; 162(10):5719-27. PubMed ID: 10229804
[TBL] [Abstract][Full Text] [Related]
18. A "three-pronged" binding mechanism for the SAP/SH2D1A SH2 domain: structural basis and relevance to the XLP syndrome.
Hwang PM; Li C; Morra M; Lillywhite J; Muhandiram DR; Gertler F; Terhorst C; Kay LE; Pawson T; Forman-Kay JD; Li SC
EMBO J; 2002 Feb; 21(3):314-23. PubMed ID: 11823424
[TBL] [Abstract][Full Text] [Related]
19. Molecular and immunological basis of X-linked lymphoproliferative disease.
Latour S; Veillette A
Immunol Rev; 2003 Apr; 192():212-24. PubMed ID: 12670406
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a new disease-causing mutation of SH2D1A in a family with X-linked lymphoproliferative disease.
Erdõs M; Uzvölgyi E; Nemes Z; Török O; Rákóczi E; Went-Sümegi N; Sümegi J; Maródi L
Hum Mutat; 2005 May; 25(5):506. PubMed ID: 15841490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
